Epigenetic Modifications as Therapeutic Targets

Yi-Chao       Zheng; Si-Qi       Feng

doi:10.2174/138945012111200727122724

« Previous Next »

[1] 
Goldberg AD, Allis CD, Bernstein E. Epigenetics: A Landscape Takes Shape. Cell  2007; 128: 635-8.
[2] 
Pechalrieu D, Etievant C, Arimondo PB. DNA methyltransferase inhibitors in cancer: From pharmacology to translational studies. Biochemical Pharmacology  2017; 129.
[3] 
McClure JJ, Li X, Chou CJ. Chapter Six - Advances and Challenges of HDAC Inhibitors in Cancer Therapeutics. In: Tew KD, Fisher PB, ed.^eds., Advances in Cancer Research. Academic Press 2018; pp. 183-211.
[4] 
Rothbart SB, Baylin SB. Epigenetic Therapy for Epithelioid Sarcoma. Cell  2020; 181: 211.

Rights & Permissions Print Cite

Article Metrics

11

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/138945012111200727122724	Print ISSN 1389-4501
Publisher Name Bentham Science Publisher	Online ISSN 1873-5592

Current Drug Targets

Epigenetic Modifications as Therapeutic Targets

Related Journals

Related Books

Related Articles